[go: up one dir, main page]

MX2009000717A - Composicion para vacuna y metodo para inmunizacion. - Google Patents

Composicion para vacuna y metodo para inmunizacion.

Info

Publication number
MX2009000717A
MX2009000717A MX2009000717A MX2009000717A MX2009000717A MX 2009000717 A MX2009000717 A MX 2009000717A MX 2009000717 A MX2009000717 A MX 2009000717A MX 2009000717 A MX2009000717 A MX 2009000717A MX 2009000717 A MX2009000717 A MX 2009000717A
Authority
MX
Mexico
Prior art keywords
vaccine composition
immunization method
recombinant
lesihmania
vaccinated
Prior art date
Application number
MX2009000717A
Other languages
English (en)
Inventor
Ana Palua Salles Moura Fernandaes
Christiane De Freitas Abrantes
Eduardo Antonio Ferraz Coelho
Ricardo Tostes Gazzinelli
Original Assignee
Univ Minas Gerais
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minas Gerais filed Critical Univ Minas Gerais
Publication of MX2009000717A publication Critical patent/MX2009000717A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/008—Leishmania antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a la vacuna recombinante contra leishmaniasis visceral canina que contiene la proteína recombinante A2 y saponina, como adyuvante, que permite la distinción entre animales vacunados y animales infectados mediante pruebas convencionales ELISA o de inmunofluorescencia que emplean antígenos de formas promastigote de Leishmania.
MX2009000717A 2006-07-21 2007-07-20 Composicion para vacuna y metodo para inmunizacion. MX2009000717A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BRPI0603490-0A BRPI0603490B1 (pt) 2006-07-21 2006-07-21 Vacina recombinante contra a leishmaniose visceral canina
PCT/BR2007/000248 WO2008009088A2 (en) 2006-07-21 2007-07-20 Vaccine composition and immunization method

Publications (1)

Publication Number Publication Date
MX2009000717A true MX2009000717A (es) 2009-06-17

Family

ID=38957122

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009000717A MX2009000717A (es) 2006-07-21 2007-07-20 Composicion para vacuna y metodo para inmunizacion.

Country Status (7)

Country Link
US (1) US8734815B2 (es)
EP (1) EP2061506B1 (es)
BR (1) BRPI0603490B1 (es)
CO (1) CO6150186A2 (es)
GT (1) GT200900012A (es)
MX (1) MX2009000717A (es)
WO (1) WO2008009088A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8968749B2 (en) * 2006-07-21 2015-03-03 Universidade Federal De Minas Gerais—Ufmg Vaccine composition and immunization method
BR102013022374B1 (pt) * 2013-09-02 2022-04-19 Universidade Federal De Minas Gerais Gene modificado de leishmania ssp., processo para obtenção de proteína e uso como antígeno em composição vacinal ou em imunodiagnóstico
BR112020016474A2 (pt) * 2018-02-13 2020-12-15 University Of Iowa Research Foundation Imunoterapia de leishmaniose

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US570591A (en) 1896-11-03 Max ams
BR9302386A (pt) 1993-06-17 1995-01-17 Univ Rio De Janeiro Composição contendo frações de células de leishmania, denominadas antígeno FML "fucose mannose ligand" ou "ligante de fucose-manose", uso de antígeno FML e de suas subfrações e componentes para as aplicações em imunodiagnóstico específico da leishmaniose visceral humana e animal, para aplicações em vacinação, tratamento ou imunoterapia contra a leishmaniose visceral humana e canina
ATE236252T1 (de) 1993-09-03 2003-04-15 Univ Mcgill Differentiell exprimierte leishmania gene und proteinen
US6485726B1 (en) * 1995-01-17 2002-11-26 The Brigham And Women's Hospital, Inc. Receptor specific transepithelial transport of therapeutics
US20020028215A1 (en) * 1999-08-09 2002-03-07 Jagath L. Kadurugamuwa Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same
US6375955B1 (en) * 1995-09-22 2002-04-23 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US20010034330A1 (en) * 1998-08-10 2001-10-25 Charlotte Kensil Innate immunity-stimulating compositions of CpG and saponin and methods thereof
US6875584B1 (en) * 1999-03-02 2005-04-05 University Of Georgia Research Foundation, Inc. Prophylactic and therapeutic immunization against protozoan infection and disease
WO2002011669A2 (en) * 2000-08-07 2002-02-14 Antigenics, Llc Compositions comprising heat shock proteins or alpha(2)macroglobulin, antigenic molecules and saponins, and methods of use thereof
US7320793B2 (en) * 2001-01-19 2008-01-22 Cytos Biotechnology Ag Molecular antigen array
AU2002303135A1 (en) * 2001-03-13 2002-09-24 Corixa Corporation Heterologous fusion protein constructs comprising a leishmania antigen
US20040170636A1 (en) * 2001-03-29 2004-09-02 Greg Matlashewski Leishmania vaccines
EP1391207A1 (en) * 2001-04-24 2004-02-25 Luis Alberto Costa Use of a phospholipase a2 for the preparation of pharmaceutical and/or cosmetic compositions for the local and/or systematic treatment and/or prevention of diseases and/or processes caused by intra- and extracellular pathogens expressing membrane phospholipids
BR0315872A (pt) * 2002-10-29 2006-07-18 Us Gov Health & Human Serv Polipeptìdeos de lutzomyia longipalpis e processos de utilização e método de uso
CN1835767A (zh) * 2003-01-29 2006-09-20 辉瑞产品公司 对抗支气管败血性博德特氏杆菌的犬疫苗
JP2006110915A (ja) * 2004-10-15 2006-04-27 Ricoh Co Ltd 印刷装置および印刷システム
WO2006110915A2 (en) * 2005-04-15 2006-10-19 University Of Iowa Research Foundation Vaccine formulations for leishmania
US8425919B2 (en) * 2008-05-21 2013-04-23 Infectious Disease Research Institute Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis

Also Published As

Publication number Publication date
EP2061506A2 (en) 2009-05-27
BRPI0603490B1 (pt) 2018-04-24
EP2061506A4 (en) 2010-04-28
CO6150186A2 (es) 2010-04-20
WO2008009088A3 (en) 2008-05-08
WO2008009088B1 (en) 2008-10-02
US8734815B2 (en) 2014-05-27
GT200900012A (es) 2010-06-22
WO2008009088A2 (en) 2008-01-24
BRPI0603490A (pt) 2008-03-11
US20110008391A1 (en) 2011-01-13
EP2061506B1 (en) 2015-10-21

Similar Documents

Publication Publication Date Title
RU2508126C2 (ru) Композиции для иммунизации против staphylococcus aureus
WO2003011223A3 (en) Immunomodulatory compounds and methods of use thereof
WO2006068663A3 (en) Vaccine compositions for treating coronavirus infection
MXPA01007760A (es) Compuesto adyuvante inmunologico.
NO20090178L (no) Vaksiner for malaria
WO2009154995A3 (en) Interleukin 10 receptor (il-10r) antibodies and methods of use
WO2016176624A3 (en) Porcine pestvirus, vaccines, and assays
NO20071523L (no) Vaksiner
EA200900024A1 (ru) Противогриппозная вакцина
EA201170812A1 (ru) Способы и композиции для применения вакцины против кокцидиоза
CY1120430T1 (el) Ανασυνδυασμενες cdv συνθεσεις και χρησεις αυτων
NO20081043L (no) Vaksine for fisk
BRPI0312194B8 (pt) vírus mononegavirales recombinante, vírus recombinante do sarampo, vetor de vírus recombinante do sarampo, sistema de resgate, composição imunogênica e composição de vacina
NZ592713A (en) Adjuvanted influenza vaccines including a cytokine-inducing agents other than an agonist of Toll-Like Receptor 9
EA201001478A1 (ru) Вакцина
MX2009000717A (es) Composicion para vacuna y metodo para inmunizacion.
AU2003288510A8 (en) Immunizing fish against viral infection
AU2001284354A1 (en) Immunological adjuvant compounds, compositions, and methods of use thereof
MX2010007876A (es) Vectores virales recombinantes y composicion de vacuna para leishmaniasis.
WO2013171661A3 (en) Adjuvant formulations and methods
EA200701801A1 (ru) Применение модифицированных поксвирусов для быстрой индукции иммунитета против поксвирусных или других инфекционных агентов
EA201200538A1 (ru) Арабиногалактан для повышения приобретенного иммунного ответа
RU2015113230A (ru) Домен CNAB SDRE STAPHYLOCOCCUS AUREUS и его применение для вакцинации
DE602004019971D1 (de) Kombinationsvakzine für geflügel
WO2004043286A3 (en) Use of rmlt as a marker antigen for vaccines and as a synergistic adjuvant with amphigen

Legal Events

Date Code Title Description
FG Grant or registration